Literature DB >> 1318743

Phase II trial with Flavone Acetic Acid (NSC.347512, LM975) in patients with non-small cell lung cancer.

P Siegenthaler1, S B Kaye, S Monfardini, J Renard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1318743     DOI： 10.1093/oxfordjournals.annonc.a058137

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  3 in total

1.  A novel combretastatin A-4 derivative, AC-7700, shows marked antitumor activity against advanced solid tumors and orthotopically transplanted tumors.

Authors:  Y Nihei; Y Suga; Y Morinaga; K Ohishi; A Okano; K Ohsumi; T Hatanaka; R Nakagawa; T Tsuji; Y Akiyama; S Saito; K Hori; Y Sato; T Tsuruo
Journal:  Jpn J Cancer Res       Date:  1999-09

2.  5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent: phase I clinical and pharmacokinetic study.

Authors:  G J S Rustin; C Bradley; S Galbraith; M Stratford; P Loadman; S Waller; K Bellenger; L Gumbrell; L Folkes; G Halbert
Journal:  Br J Cancer       Date:  2003-04-22       Impact factor: 7.640

3.  The clinical value of flow cytometric DNA content analysis in patients with soft tissue sarcomas.

Authors:  M Samur; A Pamir; H Akbulut; S Erekul; Y Sağlik; Y Yildiz; D Dinçol; F Içli
Journal:  Sarcoma       Date:  1999
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.